Industry News
New Method Introduced To Closely Model Diseases Caused By Splicing Defects
Aug 15, 2012
A team led by scientists at Cold Spring Harbor Laboratory (CSHL) has developed a new way of making animal models for a broad class of human genetic diseases - those with pathology caused by errors in the splicing of RNA messages copied from genes. To date, about 6,000 such RNA "editing" errors have been found in various human illnesses, ranging from neurodegenerative disorders to cancer... Read More
How Cancer Cells "Hijack" A Mechanism To Grow
Aug 15, 2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have discovered a mechanism that explains how some cancer cells "hijack" a biological process to potentially activate cell growth and the survival of cancer gene expression. Their study appeared in a recent issue of Nature Structural & Molecular Biology... Read More
Personalized Clinical Trial For Cancer Therapies May Be Possible With New Method
Aug 15, 2012
A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy - and may offer a way to further refine personalized cancer treatments... Read More
Personalized Clinical Trial For Cancer Therapies May Be Possible With New Method
Aug 15, 2012
A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy - and may offer a way to further refine personalized cancer treatments... Read More
Mechanisms Of Acquired Chemoresistance In Ovarian Cancer Identified
Aug 15, 2012
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment... Read More
Scientists Develop Model For New Burkitt Lymphoma Treatments
Aug 15, 2012
Burkitt lymphoma is a malignant, fast-growing tumor that originates from a subtype of white blood cells called B lymphocytes of the immune system and often affects internal organs and the central nervous system. Now Dr... Read More
Scientists Develop Model For New Burkitt Lymphoma Treatments
Aug 15, 2012
Burkitt lymphoma is a malignant, fast-growing tumor that originates from a subtype of white blood cells called B lymphocytes of the immune system and often affects internal organs and the central nervous system. Now Dr... Read More
New Treatment Options For High-Risk Childhood Leukemia Subtype Offered By Existing Drugs
Aug 15, 2012
Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with exist... Read More
New Treatment Options For High-Risk Childhood Leukemia Subtype Offered By Existing Drugs
Aug 15, 2012
Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with exist... Read More
Sensitivity To Potential Glioblastoma Treatment Affected By Modification Of Tumor Suppressor
Aug 15, 2012
Despite years of research, glioblastoma, the most common and deadly brain cancer in adults, continues to outsmart treatments targeted to inhibit tumor growth. Biologists and oncologists have long understood that a protein called the epidermal growth factor receptor or EGFR is altered in at least 50 percent of patients with glioblastoma... Read More
Previous Page Next Page